METABOLOMICS SERVICES MARKET ANALYSIS

Metabolomics Services Market, by Service Type (Targeted Metabolomics Service, Untargeted Metabolomics Service), by Technique (Detection Techniques (Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS)), Separation Techniques (Gas Chromatography (GC), Capillary Electrophoresis (CE), Liquid Chromatography (LC), Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)), by Application (Drug Assessment, Biomarker Discovery, Nutrigenomics, Clinical toxicology, Others (Crop Breeding, Disease Diagnosis, etc.)), by End User (Academics and Research Labs, Biotechnology and Pharmaceutical Companies, and Diagnostic Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Dec 2022
Code : CMI180
Pages :256
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Leading Companies

Global Metabolomics Services Market - Key Players

Major players operating in the global metabolomics services market include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., SCIEX (Danaher), Waters Corporation, Shimadzu Corporation, Bruker, Human Metabolome Technologies Inc., LECO Corporation, Biocrates life sciences AG, Metabolon, Inc., Metabolomic Technologies Inc., PerkinElmer Inc., Analytik Jena GmbH, Creative Proteomics, Vproteomics, DNA Xperts Private Limited, MS-OMICS, metaSysX, BASF SE, BGI, Afekta Technologies Ltd., Metware Biotechnology Co.,Ltd.